TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vicore Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
530
|
2,687
|
2,863 |
Financial expenses |
2
|
5
|
422 |
Earnings before taxes |
-285,515
|
-261,209
|
-284,632 |
EBITDA |
-273,250
|
-261,359
|
-282,691 |
Total assets |
115,843
|
115,781
|
182,354 |
Current assets |
114,786
|
101,968
|
172,445 |
Current liabilities |
70,700
|
46,498
|
89,116 |
Equity capital |
44,322
|
68,353
|
92,999 |
- share capital |
101
|
95
|
98 |
Employees (average) |
19
|
16
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
38.3%
|
59.0%
|
51.0% |
Turnover per employee |
28
|
168
|
239 |
Profit as a percentage of turnover |
-53870.8%
|
-9721.2%
|
-9941.7% |
Return on assets (ROA) |
-246.5%
|
-225.6%
|
-155.9% |
Current ratio |
162.4%
|
219.3%
|
193.5% |
Return on equity (ROE) |
-644.2%
|
-382.1%
|
-306.1% |
Change turnover |
-2,348
|
-90
|
-36 |
Change turnover % |
-82%
|
-3%
|
-1% |
Chg. No. of employees |
3
|
4
|
3 |
Chg. No. of employees % |
19%
|
33%
![]() |
33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.